Horizon Therapeutics PLC
Change company Symbol lookup
Select an option...
HZNP Horizon Therapeutics PLC
FBSI First Bancshares Inc (Missouri)
KGDEY Kingdee International Software Group Co Ltd
CMRA Comera Life Sciences Holdings Inc
ADI Analog Devices Inc
KEY KeyCorp
FNF Fidelity National Financial Inc
CTAQU Carney Technology Acquisition Corp. II
MUE BlackRock MuniHoldings Quality Fund II, Inc.
NC NACCO Industries Inc
Go

Health Care : Biotechnology | Mid Cap Blend
Based in Ireland
Company profile

Horizon Therapeutics plc is a global biotechnology company. The Company is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The Company's portfolio is composed of approximately 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. The Company operates through two segments: orphan segment and the inflammation segment. The orphan segment includes medicines, such as TEPEZZA (teprotumumab-trbw), KRYSTEXXA (pegloticase injection), RAVICTI (glycerol phenylbutyrate), PROCYSBI (cysteamine bitartrate), UPLIZNA (inebilizumab-cdon) injection, ACTIMMUNE (interferon gamma-1b) injection, BUPHENYL (sodium phenylbutyrate) tablets and powder, and QUINSAIR (levofloxacin) solution. The inflammation segment includes medicines, such as PENNSAID (diclofenac sodium topical solution), RAYOS (prednisone), VIMOVO (naproxen), and DUEXIS (ibuprofen).

Price
Delayed
$66.49
Day's Change
0.33 (0.50%)
Bid
--
Ask
--
B/A Size
--
Day's High
67.23
Day's Low
65.55
Volume
(Average)

Today's volume of 1,936,713 shares is on pace to be in-line with HZNP's 10-day average volume of 2,784,917 shares.

1,936,713
  • Prev Close
    66.16
  • Today's Open
    65.87
  • Day's Range
    65.55-67.23
  • Avg Vol (10-day)
    2.8M
  • Last (time)
    2:15p ET 10/05/22
  • Last (size)
    200
  • 52-Wk Range
    57.84 - 120.54
    LowHigh
  • (11/01/21 - 09/01/22)
    14.96%
  • 39.9%
  • Market Cap
    15.3B
  • Shares Outstanding
    230.4M
  • 3.24
  • 19.09x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.2
  • 92.33
  • (% of float 09/15/22)
    2.46

Latest News

October 02, 2022
11:15 am ET
BusinessWire
September 29, 2022
8:00 am ET
BusinessWire
September 22, 2022
8:04 am ET
BusinessWire
September 21, 2022
8:04 am ET
BusinessWire
7:30 am ET
PR Newswire
September 19, 2022
8:00 am ET
BusinessWire
September 16, 2022
9:00 am ET
BusinessWire
September 14, 2022
8:00 am ET
BusinessWire
September 13, 2022
8:30 am ET
BusinessWire
September 12, 2022
8:00 am ET
BusinessWire
September 09, 2022
8:00 am ET
BusinessWire
September 08, 2022
8:03 am ET
BusinessWire
August 31, 2022
9:03 am ET
BusinessWire
August 29, 2022
4:00 am ET
BusinessWire
August 25, 2022
8:00 am ET
BusinessWire
August 15, 2022
8:00 am ET
PR Newswire
8:00 am ET
BusinessWire
August 04, 2022
8:45 am ET
MarketWatch
August 03, 2022
7:00 am ET
BusinessWire
July 25, 2022
8:02 am ET
BusinessWire
July 21, 2022
8:00 am ET
BusinessWire
July 11, 2022
8:00 am ET
BusinessWire
July 08, 2022
8:00 am ET
BusinessWire
June 14, 2022
10:52 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.